NUMOTECH INC.
See us at Arab Health 2025 · Booth: H1.C50B
Numotech Inc. has two products:
• The Numobag® Disposable Isolation System (N-DIS) has a tested isolation efficiency of greater than 99%.
• The Numobag® is a clinically validated, single use device that delivers Topical Hyperbaric Oxygen (THOT®) to heal wounds without scar tissue.
Northridge, California (CA), United States
Healthcare
Products & Services
People
About
Connect with us at
Arab Health 2025 : Booth H1.C50B
Products & Services
Numobag® Kit
Numotech Inc.
The Numobag® Kit is a specially designed and clinically validated system that allows for safe, easy, and effective application of Topical Hyperbaric Oxygen Therapy (THOT®). The Numobag® is an FDA cleared Class II device to treat diabetic ulcers, pressure sores, burns—thermal and chemical—and other traumatic wounds with minimal scarring. The device is cost-effective in rapidly healing large skin lesions.
The Numobag® can be used in hospital, clinic, or home. Multiple patients can be treated simultaneously. The Numobag® is small, portable, and disposable to prevent cross contamination. The Numobag® is cost effective: it reduces nursing time, antibiotics, debridement, specialty beds, and length of stay. Faster healing greatly improves patient psychosocial attitude and morale.
The Numobag® can be used in hospital, clinic, or home. Multiple patients can be treated simultaneously. The Numobag® is small, portable, and disposable to prevent cross contamination. The Numobag® is cost effective: it reduces nursing time, antibiotics, debridement, specialty beds, and length of stay. Faster healing greatly improves patient psychosocial attitude and morale.
Numobag® Disposable Isolation System (N-DIS)
Numotech Inc.
N-DIS is a portable, easily deployed, low cost, and sole use disposable infectious disease containment system allowing infectious patients to be safely transported while being fully encapsulated in a medical grade oxygen enriched clear polyethylene membrane. The N-DIS is designed to minimize risk to the patient and front- line personnel. The N-DIS will be critical for first responder and medical staff protection against infectious and contagious pathogens such as SARS-CoV-2 COVID 19, A H5N1 Bird Flu, Human Metapneumovirus HMPV, Monkeypox Clade 1, Ebola and others while infected patients are being transported and/or isolated. Given constant re-exposure to respiratory pathogens, front-line medical personnel and first responders have the second highest rates of serious illness and death.
In 2023, the N-DIS was tested by the U.S. Army’s premier testing facility which reported that the isolation efficacy rating of the N-DIS was greater than 99.99% for viral and bacterial pathogens. The N-DIS can isolate contaminated patients during transport and protect first responders and medical personnel. The N-DIS can also protect vulnerable patients with severely compromised immune systems from airborne and surface pathogens. The N-DIS is easy to use, low cost, disposable, and meets all quarantine protocols. The N-DIS contains the contaminated exhaust from the patient in a HEPA filter. The N-DIS membrane and HEPA filter exhaust system can be disposed of as biohazard waste after the patient is removed from the N-DIS.
The N-DIS supplements standard PPE and captures viral and bacterial particles emitted from a patient’s body, preventing exposure to EMT personnel, first responders, nurses, and physicians from pathogenic biological airborne particulates. The N-DIS will also be useful for U.S. military personnel who are facing an ever-growing challenge from infectious pathogens. Along with rapid isolation of the patient, another critical operational consideration is patient safety. The emplacement of the N-DIS does not cause undue physical discomfort for the patient which would impede rapid and effective isolation. The patient can be transported and monitored comfortably.
The N-DIS is expected to be a market leader based on performance, pricing, portability, and ease of implementation, personnel training, and disposability compared to competing products.
In 2023, the N-DIS was tested by the U.S. Army’s premier testing facility which reported that the isolation efficacy rating of the N-DIS was greater than 99.99% for viral and bacterial pathogens. The N-DIS can isolate contaminated patients during transport and protect first responders and medical personnel. The N-DIS can also protect vulnerable patients with severely compromised immune systems from airborne and surface pathogens. The N-DIS is easy to use, low cost, disposable, and meets all quarantine protocols. The N-DIS contains the contaminated exhaust from the patient in a HEPA filter. The N-DIS membrane and HEPA filter exhaust system can be disposed of as biohazard waste after the patient is removed from the N-DIS.
The N-DIS supplements standard PPE and captures viral and bacterial particles emitted from a patient’s body, preventing exposure to EMT personnel, first responders, nurses, and physicians from pathogenic biological airborne particulates. The N-DIS will also be useful for U.S. military personnel who are facing an ever-growing challenge from infectious pathogens. Along with rapid isolation of the patient, another critical operational consideration is patient safety. The emplacement of the N-DIS does not cause undue physical discomfort for the patient which would impede rapid and effective isolation. The patient can be transported and monitored comfortably.
The N-DIS is expected to be a market leader based on performance, pricing, portability, and ease of implementation, personnel training, and disposability compared to competing products.
People
Abubaker Moosa
Numotech Inc.
Middle East Executive
Artur Arustamyan
Numotech Inc.
President, Bon Pharm Food Supplements Trading LLC, the UAE sales office for Numotech, Inc. products
Dr. Robert Felton
Numotech Inc.
President and CEO
Arab Health 2025
Dr. Sarkis Mesrobian
Numotech Inc.
President, Portable Isolation Systems, Inc.
Kristina Talishyan
Numotech Inc.
Director, Bon Pharm Food Supplements, LLC, the UAE sales office for Numotech, Inc. products
Yelena Mikhaylenko
Numotech Inc.
International Business Manager
Connect with us at
Arab Health 2025
???
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Companies
People
Products
Bookmark your results to build your Event Planner for Arab Health 2025
About
THE NUMOBAG®
The Numobag® is a specially designed and clinically validated wound care system that allows for safe, easy, and effective application of Topical Hyperbaric Oxygen Therapy (THOT®). The Numobag® is a Class II device cleared to treat diabetic ulcers, pressure sores, burns—thermal and chemical—and other traumatic wounds with minimal scarring. The device is cost-effective in rapidly healing large skin lesions.
The Numobag® can be used in hospital, clinic, or home. Multiple patients can be treated simultaneously. The Numobag® is small, portable, and disposable to prevent cross contamination. The Numobag® is cost effective: it reduces nursing time, antibiotics, debridement, specialty beds, and length of stay. Faster healing greatly improves patient psychosocial attitude and morale.
THE NUMOBAG® DISPOSABLE ISOLATION SYSTEM (N-DIS)
The Numobag® Disposable Isolation System (N-DIS) is a single use isolation unit suitable for isolating patients with Covid-19, Ebola, and other infectious diseases. The unit is portable, easily deployed, and disposable. Its use minimizes exposure to medical and other personnel in contact with infected patients. Infectious patients can be transported through uncontaminated areas and uninfected patients can be transported through contaminated areas.
The isolation efficiency of the N-DIS has been proven at 99.9% and above by the U.S. Army Combat Capabilities Development Command (DEVCOM). The device uses a High Efficiency Particulate Absorbing (HEPA) filter to remove 99.9% of 0.3 micron particles from the air including bacteria, viruses, and other pathogens.
N-DIS can be used by physicians, nurses, EMTs, first responders, firefighters, and military personnel.
CONTACT US
Numotech is located in southern California. Call us toll free at +1 877-686-6832, visit us on the web at numotech.net, or email us at numotech@earthlink.net.
The Numobag® is a specially designed and clinically validated wound care system that allows for safe, easy, and effective application of Topical Hyperbaric Oxygen Therapy (THOT®). The Numobag® is a Class II device cleared to treat diabetic ulcers, pressure sores, burns—thermal and chemical—and other traumatic wounds with minimal scarring. The device is cost-effective in rapidly healing large skin lesions.
The Numobag® can be used in hospital, clinic, or home. Multiple patients can be treated simultaneously. The Numobag® is small, portable, and disposable to prevent cross contamination. The Numobag® is cost effective: it reduces nursing time, antibiotics, debridement, specialty beds, and length of stay. Faster healing greatly improves patient psychosocial attitude and morale.
THE NUMOBAG® DISPOSABLE ISOLATION SYSTEM (N-DIS)
The Numobag® Disposable Isolation System (N-DIS) is a single use isolation unit suitable for isolating patients with Covid-19, Ebola, and other infectious diseases. The unit is portable, easily deployed, and disposable. Its use minimizes exposure to medical and other personnel in contact with infected patients. Infectious patients can be transported through uncontaminated areas and uninfected patients can be transported through contaminated areas.
The isolation efficiency of the N-DIS has been proven at 99.9% and above by the U.S. Army Combat Capabilities Development Command (DEVCOM). The device uses a High Efficiency Particulate Absorbing (HEPA) filter to remove 99.9% of 0.3 micron particles from the air including bacteria, viruses, and other pathogens.
N-DIS can be used by physicians, nurses, EMTs, first responders, firefighters, and military personnel.
CONTACT US
Numotech is located in southern California. Call us toll free at +1 877-686-6832, visit us on the web at numotech.net, or email us at numotech@earthlink.net.
Add Attachment
Share
Recent Chats
Share via email
Future: handle WhatsApp here
Future: handle LinkedIn here
Future: handle Twitter here
SUBMENU HERE
Share via Chat
Copy Link